Clinical Trial Imaging Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241759

Publication Date:

October 24, 2024

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
The global market for Clinical Trial Imaging Service was estimated to be worth US$ 1379.4 million in 2023 and is forecast to a readjusted size of US$ 2281.9 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Imaging Service by region & country, by Type, and by Application.
The Clinical Trial Imaging Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging Service.
麻豆原创 Segmentation
By Company
Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc
Segment by Type:
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clinical Trial Imaging Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Clinical Trial Imaging Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Clinical Trial Imaging Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Clinical Trial Imaging Service Product Introduction
1.2 Global Clinical Trial Imaging Service 麻豆原创 Size Forecast
1.3 Clinical Trial Imaging Service 麻豆原创 Trends & Drivers
1.3.1 Clinical Trial Imaging Service Industry Trends
1.3.2 Clinical Trial Imaging Service 麻豆原创 Drivers & Opportunity
1.3.3 Clinical Trial Imaging Service 麻豆原创 Challenges
1.3.4 Clinical Trial Imaging Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clinical Trial Imaging Service Players Revenue Ranking (2023)
2.2 Global Clinical Trial Imaging Service Revenue by Company (2019-2024)
2.3 Key Companies Clinical Trial Imaging Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Clinical Trial Imaging Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Clinical Trial Imaging Service
2.6 Clinical Trial Imaging Service 麻豆原创 Competitive Analysis
2.6.1 Clinical Trial Imaging Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Imaging Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 In-house Imaging Service
3.1.2 Central Imaging Service
3.2 Global Clinical Trial Imaging Service Sales Value by Type
3.2.1 Global Clinical Trial Imaging Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clinical Trial Imaging Service Sales Value, by Type (2019-2030)
3.2.3 Global Clinical Trial Imaging Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Companies
4.1.2 Biotechnology Companies
4.1.3 Medical Device Manufacturers
4.1.4 Research Institutes
4.1.5 Others
4.2 Global Clinical Trial Imaging Service Sales Value by Application
4.2.1 Global Clinical Trial Imaging Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clinical Trial Imaging Service Sales Value, by Application (2019-2030)
4.2.3 Global Clinical Trial Imaging Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Clinical Trial Imaging Service Sales Value by Region
5.1.1 Global Clinical Trial Imaging Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clinical Trial Imaging Service Sales Value by Region (2019-2024)
5.1.3 Global Clinical Trial Imaging Service Sales Value by Region (2025-2030)
5.1.4 Global Clinical Trial Imaging Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Clinical Trial Imaging Service Sales Value, 2019-2030
5.2.2 North America Clinical Trial Imaging Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Clinical Trial Imaging Service Sales Value, 2019-2030
5.3.2 Europe Clinical Trial Imaging Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Clinical Trial Imaging Service Sales Value, 2019-2030
5.4.2 Asia Pacific Clinical Trial Imaging Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Clinical Trial Imaging Service Sales Value, 2019-2030
5.5.2 South America Clinical Trial Imaging Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Clinical Trial Imaging Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Clinical Trial Imaging Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clinical Trial Imaging Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clinical Trial Imaging Service Sales Value
6.3 United States
6.3.1 United States Clinical Trial Imaging Service Sales Value, 2019-2030
6.3.2 United States Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clinical Trial Imaging Service Sales Value, 2019-2030
6.4.2 Europe Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clinical Trial Imaging Service Sales Value, 2019-2030
6.5.2 China Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clinical Trial Imaging Service Sales Value, 2019-2030
6.6.2 Japan Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clinical Trial Imaging Service Sales Value, 2019-2030
6.7.2 South Korea Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clinical Trial Imaging Service Sales Value, 2019-2030
6.8.2 Southeast Asia Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clinical Trial Imaging Service Sales Value, 2019-2030
6.9.2 India Clinical Trial Imaging Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clinical Trial Imaging Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bioclinica
7.1.1 Bioclinica Profile
7.1.2 Bioclinica Main Business
7.1.3 Bioclinica Clinical Trial Imaging Service Products, Services and Solutions
7.1.4 Bioclinica Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.1.5 Bioclinica Recent Developments
7.2 Parexel International Corporation
7.2.1 Parexel International Corporation Profile
7.2.2 Parexel International Corporation Main Business
7.2.3 Parexel International Corporation Clinical Trial Imaging Service Products, Services and Solutions
7.2.4 Parexel International Corporation Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.2.5 Parexel International Corporation Recent Developments
7.3 Icon
7.3.1 Icon Profile
7.3.2 Icon Main Business
7.3.3 Icon Clinical Trial Imaging Service Products, Services and Solutions
7.3.4 Icon Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.3.5 Biomedical Systems Corporation (ERT) Recent Developments
7.4 Biomedical Systems Corporation (ERT)
7.4.1 Biomedical Systems Corporation (ERT) Profile
7.4.2 Biomedical Systems Corporation (ERT) Main Business
7.4.3 Biomedical Systems Corporation (ERT) Clinical Trial Imaging Service Products, Services and Solutions
7.4.4 Biomedical Systems Corporation (ERT) Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.4.5 Biomedical Systems Corporation (ERT) Recent Developments
7.5 Biotelemetry
7.5.1 Biotelemetry Profile
7.5.2 Biotelemetry Main Business
7.5.3 Biotelemetry Clinical Trial Imaging Service Products, Services and Solutions
7.5.4 Biotelemetry Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.5.5 Biotelemetry Recent Developments
7.6 Cardiovascular Imaging Technologies
7.6.1 Cardiovascular Imaging Technologies Profile
7.6.2 Cardiovascular Imaging Technologies Main Business
7.6.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Service Products, Services and Solutions
7.6.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.6.5 Cardiovascular Imaging Technologies Recent Developments
7.7 Intrinsic Imaging
7.7.1 Intrinsic Imaging Profile
7.7.2 Intrinsic Imaging Main Business
7.7.3 Intrinsic Imaging Clinical Trial Imaging Service Products, Services and Solutions
7.7.4 Intrinsic Imaging Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.7.5 Intrinsic Imaging Recent Developments
7.8 Ixico
7.8.1 Ixico Profile
7.8.2 Ixico Main Business
7.8.3 Ixico Clinical Trial Imaging Service Products, Services and Solutions
7.8.4 Ixico Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.8.5 Ixico Recent Developments
7.9 Radiant Sage
7.9.1 Radiant Sage Profile
7.9.2 Radiant Sage Main Business
7.9.3 Radiant Sage Clinical Trial Imaging Service Products, Services and Solutions
7.9.4 Radiant Sage Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.9.5 Radiant Sage Recent Developments
7.10 Worldcare Clinical
7.10.1 Worldcare Clinical Profile
7.10.2 Worldcare Clinical Main Business
7.10.3 Worldcare Clinical Clinical Trial Imaging Service Products, Services and Solutions
7.10.4 Worldcare Clinical Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.10.5 Worldcare Clinical Recent Developments
7.11 Micron, Inc
7.11.1 Micron, Inc Profile
7.11.2 Micron, Inc Main Business
7.11.3 Micron, Inc Clinical Trial Imaging Service Products, Services and Solutions
7.11.4 Micron, Inc Clinical Trial Imaging Service Revenue (US$ Million) & (2019-2024)
7.11.5 Micron, Inc Recent Developments
8 Industry Chain Analysis
8.1 Clinical Trial Imaging Service Industrial Chain
8.2 Clinical Trial Imaging Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clinical Trial Imaging Service Sales Model
8.5.2 Sales Channel
8.5.3 Clinical Trial Imaging Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.